Compare HDFC Pharma And Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.97
1.88
NAV
₹19.29
₹466.26
Fund Started
14 Sep 2023
04 Jun 1999
Fund Size
₹2158.58 Cr
₹4323.29 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
19.13%
11.27%
3 Year
-
26.71%
5 Year
-
15.78%
Equity
97.30%
97.38%
Cash
2.70%
2.55%
Top 10 Holdings
Divi's Laboratories Ltd. | 8.56% |
Sun Pharmaceutical Industries Ltd. | 8.05% |
Lupin Ltd. | 6.07% |
Glenmark Pharmaceuticals Ltd. | 6.06% |
Max Healthcare Institute Ltd. | 5.93% |
Aster DM Healthcare Ltd. | 5.46% |
Alkem Laboratories Ltd. | 4.69% |
Anthem Biosciences Ltd. | 4.55% |
Ipca Laboratories Ltd. | 4.39% |
Cipla Ltd. | 4.27% |
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 6.77% |
Acutaas Chemicals Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.30% |
Max Healthcare Institute Ltd. | 5.17% |
Aster DM Healthcare Ltd. | 3.89% |
Lupin Ltd. | 3.84% |
Torrent Pharmaceuticals Ltd. | 3.48% |
Anthem Biosciences Ltd. | 3.45% |
Aether Industries Ltd. | 3.35% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
14 Sep 2023
04 Jun 1999
